Reports for ALLERGAN INC

Company Name

ALLERGAN INC

Totals

Shortage reports

39

Actual shortage: 3 (8%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 36 (92%)

Discontinuation Reports

25

To be discontinued: 1 (4%)
Discontinued: 22 (88%)
Reversed: 2 (8%)

Late reports

17 (27%)

Overdue reports

3 (75%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINESTRIN 1/20 20MCG 1MG TABLET Resolved 2019-10-10 2019-11-04 96092
MINESTRIN 1/20 1MG 20MCG TABLET Resolved 2020-12-18 2021-02-26 130395
LOESTRIN 1.5/30 30MCG 1.5MG TABLET Resolved 2019-10-10 2019-12-25 96098
LOESTRIN 1.5/30 1.5MG 30MCG TABLET Resolved 2020-12-18 2021-01-23 130392
TAZORAC 0.05% GEL Resolved 2018-11-01 2019-05-18 65978
TAZORAC 0.05% GEL Resolved 2021-08-13 2021-12-23 144130
TAZORAC 0.1% GEL Resolved 2018-11-02 2018-12-01 66125
TAZORAC 0.1% GEL Resolved 2020-06-16 2021-04-15 118029
ANDRODERM 2.5MG PATCH Resolved 2021-01-19 2021-01-21 131988
ANDRODERM 2.5MG PATCH Resolved 2021-06-07 2021-09-02 140514
TAZORAC 0.05% CREAM Resolved 2018-11-02 2018-12-01 66116
TAZORAC 0.05% CREAM Resolved 2019-09-16 2019-11-08 93944
TAZORAC 0.1% CREAM Resolved 2019-09-16 2020-03-10 93947
ANDRODERM 24.3MG PATCH Resolved 2018-03-07 2018-09-25 42174
OXYTROL 36MG PATCH Resolved 2018-09-25 2018-11-03 62335
ASACOL 800 800MG TABLET (DELAYED-RELEASE) Resolved 2020-07-14 2021-01-28 120327
RAPAFLO 4MG CAPSULE Resolved 2018-07-20 2018-09-25 56121
RAPAFLO 8MG CAPSULE Resolved 2019-09-16 2019-10-26 93953
FIBRISTAL 5MG TABLET Resolved 2020-09-24 2020-10-23 125019

Showing 21 to 39 of 39

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RAPAFLO 8MG CAPSULE Discontinued 2021-11-17 2022-11-14 149531
FIBRISTAL 5MG TABLET Discontinued 2020-10-06 2020-10-06 125735
VIBERZI 75MG TABLET Reversed 2022-03-23 2022-06-29 157156
VIBERZI 100MG TABLET Reversed 2022-03-23 2022-06-22 157159
BLEPHAMIDE 0.2% 10% DROPS To be discontinued 2021-12-02 2021-12-02 150359

Showing 21 to 25 of 25